MedPath

A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer

Completed
Conditions
Non-small Cell Lung Cancer
Interventions
Procedure: Sublobar dissection
Registration Number
NCT03427567
Lead Sponsor
Tongji Hospital
Brief Summary

A study to evaluate effectiveness of sublobar dissection in patients with non-small cell lung cancer

Detailed Description

This is a multi-centre real-world non-interventional observational study. The study data on patient demographic/tumor biological characteristics and clinical treatments were retrospectively collected to evaluate effectiveness of sublobar dissection in the Chinese patients with non-small cell lung cancer who received sublobar dissection.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3902
Inclusion Criteria
  • Patients >= 18 years old;
  • Patients who received sublobar dissection from 2014 to 2017 (segment dissection/wedge dissection/segment and wedge dissections);
  • Patients who received selective or systematic lymphadenectomy;
  • Pathologically diagnosed patients with non-small cell lung cancer;
  • Pathological staging: I, II
Exclusion Criteria
  • Patients who received cancer treatments before surgeries (adjuvant therapies including chemotherapies, radiotherapies, target therapies);
  • Patients who received late-phase or intolerant palliative lobectomy or compromise sublobar dissection;

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Sublobar dissectionSublobar dissectionChinese NSCLC patients who received sublobar dissection
Primary Outcome Measures
NameTimeMethod
Overall survival2014 - 2017

Overall survival

Secondary Outcome Measures
NameTimeMethod
Overall survivals in subgroups2014 - 2017

Overall survivals categorised by tumor biological characteristics

Trial Locations

Locations (10)

China-Japan Friendship Hospital

🇨🇳

Beijing, Beijing, China

Henan cancer hospital

🇨🇳

Zhengzhou, Henan, China

Jiangsu cancer hospital

🇨🇳

Nanjing, Jiangsu, China

China PLA General Hospital

🇨🇳

Beijing, Beijing, China

Tongji Hospital Affiliated to Huazhong Technology Hospital

🇨🇳

Wuhan, Hubei, China

Xi'an Tangdu Hospital

🇨🇳

Xi'an, Shaanxi, China

Shanghai Chest Hospital

🇨🇳

Shanghai, Shanghai, China

Huaxi Hospital Affiliated to Sichuan University

🇨🇳

Chengdu, Sichuan, China

Tianjin Chest Hospital

🇨🇳

Tianjin, Tianjin, China

First Hospital Affiliated to Zhejiang University

🇨🇳

Hangzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath